Antibiotic may provide benefit for treatment of respiratory disorder
Among patients with the lung disorder non-cystic fibrosis bronchiectasis, treatment with the antibiotic erythromycin resulted in improvement in symptoms but also increased the risk of antibiotic resistance, according to a ...
Diseases, Conditions, Syndromes
Mar 26, 2013 |
not rated yet |
0
|
Inhaler approved for cystic fibrosis patients
(HealthDay)—The TOBI Podhaler (tobramycin inhalation powder) has been approved by the U.S. Food and Drug Administration to treat cystic fibrosis patients infected with Pseudomonas aeruginosa, a bacterium that can damage ...
Medications
Mar 25, 2013 |
not rated yet |
0
Scientists discover potential new target in fight against 'superbug'
University of Cambridge researchers have discovered how an antibiotic-resistant superbug exploits oxygen-limited conditions in the lungs of patients with severe respiratory disease to thrive.
Medical research
Jan 29, 2013 |
5 / 5 (1) |
0
Ultrasound gel and infections: Researchers propose guidelines to reduce risk
In the December issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America, guidelines have been proposed by epidemiologists from Beaumont Health System to red ...
Diseases, Conditions, Syndromes
Nov 12, 2012 |
5 / 5 (1) |
0
New plasma jet gives 'cold' shoulder to 'superbugs'
Scientists at Queen's University Belfast have developed a new technique which has the potential to kill off hospital superbugs like Pseudomonas aeruginosa, C. difficile and MRSA.
Medical research
Oct 03, 2012 |
5 / 5 (2) |
0
|
Healthy lungs' microbes focus of study on cystic fibrosis
(Medical Xpress)—Healthy people's lungs are home to a diverse community of microbes that differs markedly from the bacteria found in the lungs of cystic fibrosis patients. That's the result of new research from Stanford ...
Medical research
Sep 27, 2012 |
not rated yet |
0
|
P. aeruginosa bacteria associated with increased hospitalizations in COPD patients
Patients with chronic obstructive pulmonary disease (COPD) who become infected with the bacterium Pseudomonas aerguinosa are more likely to have worse clinical outcomes and experience more hospitalizations during the course ...
Diseases, Conditions, Syndromes
May 23, 2012 |
not rated yet |
0
'Resuscitating' antibiotics to overcome drug resistance
Combining common antibiotics with additional compounds could make previously resistant bacteria more susceptible to the same antibiotics. 'Resuscitation' of existing antibiotics has the potential to make infections caused ...
Medications
Mar 28, 2012 |
5 / 5 (1) |
0
Clinical trial to test success of Cystic Fibrosis lung infection treatment
Experts from Bristol and Nottingham are leading a major new national study to investigate whether intravenous antibiotics are effective in killing a common germ that causes dangerous complications in cystic fibrosis (CF) ...
Diseases, Conditions, Syndromes
Mar 27, 2012 |
not rated yet |
0
Parallel evolution - cystic fibrosis
(Medical Xpress) -- Researchers at the University of Liverpool are examining the evolution of Pseudomonas aeruginosa over time in the lungs of ten people with cystic fibrosis to understand why it persists ...
Medical research
Mar 06, 2012 |
5 / 5 (3) |
0
|
New automated system to kill bacteria in hospital water systems and taps
A team of Trinity College Dublin researchers has developed a fully automated system that eradicates bacterial contamination in hospital water tanks, distribution systems and taps. This type of contamination ...
Diseases, Conditions, Syndromes
Mar 05, 2012 |
5 / 5 (1) |
0
Early cystic fibrosis lung disease detected by bronchoalveolar lavage and lung clearance index
The lung clearance index (LCI) is a sensitive non-invasive marker of early lung disease in young children with cystic fibrosis (CF), according to a new study from Australian researchers.
Diseases, Conditions, Syndromes
Jan 27, 2012 |
not rated yet |
0
Targeting bacterial gas defenses allow for increased efficacy of numerous antibiotics
Although scientists have known for centuries that many bacteria produce hydrogen sulfide (H2S) it was thought to be simply a toxic by-product of cellular activity. Now, researchers at NYU School of Medicine have discovered ...
Medical research
Nov 17, 2011 |
not rated yet |
0
|
An antibiotic effect minus resistance
After 70 years, antibiotics are still the primary treatment for halting the spread of bacterial infections. But the prevalence of antibiotic resistance is now outpacing the rate of new drug discovery and approval.
Medical research
Oct 28, 2011 |
5 / 5 (3) |
0
|
Study proves new technology kills bacteria
Results from a comprehensive multi-site clinical trial demonstrated that the use of antimicrobial copper surfaces in intensive care unit rooms reduced the amount of bacteria in the rooms by 97 percent and resulted in a 41 ...
Diseases, Conditions, Syndromes
Oct 20, 2011 |
5 / 5 (1) |
0
